Case Study Analysis: Hematuria, Differential Diagnosis, Treatment

This case study analyzes a patient presenting with hematuria, focusing on differential diagnosis, potential treatments, and health promotion strategies. The analysis begins by differentiating between renal and non-renal causes of hematuria, considering conditions like nephrolithiasis, nephron damage, and the patient's history of ulcerative colitis. The study then explores various treatment options based on the diagnosis, including medications for inflammation, interventions for kidney stones like surgery or shock wave lithotripsy, and biopsies for non-glomerular diseases. Health promotional activities, such as increased water intake and lifestyle changes, are recommended. The case study concludes with a discussion on the evaluation of the current treatment, emphasizing the importance of monitoring the patient's pain levels, blood loss, and overall health improvement through regular screenings and urine sample analysis. References are provided for further study.

Running head: CASE STUDY ANALYSIS
CASE STUDY ANALYSIS
Name of the student
Name of the university
Author note

1CASE STUDY ANALYSIS
Differential diagnosis of hematuria
Hematuria is the critical health condition in which the affected person’s urine contains
red blood cells (Bolenz et al., 2018). However, there are other health conditions in which the
blood cells could be observed in the urine of patients. In this condition, differential diagnosis
of hematuria should be discussed (Hasan, Patel & Siegert, 2019). The differential diagnosis
of hematuria should be divided among renal (glomerular) and non- renal (non- glomerular)
due to which majority of the patients are observed with blood clots in their urine. Besides
this, malignancy, or benign diseases associated with kidney diseases would be an effective
step for the presence of blood clot in the urine sample (Pochineni, Randhawa & Puttarajappa,
2018). Renal conditions such as presence of Nephrolithiasis or kidney stones, nephron related
damages and other health conditions, people develop signs of hematuria (Bolenz et al., 2018).
Therefore, these are the differential diagnosis that is associated with the signs and symptoms
of hematuria.
Potential treatment
Depending upon the differential diagnosis provided, the patient should be provided
with effective and quality treatment. For example, for his past ulcerative colitis, which could
also lead to conditions related to hematuria, the patient might be provided with medications
related to his inflammation in bowel such as meslalamine, balsalazide, and olsalazine so that
they could improvement their health condition (Filion et al., 2017). Whereas, for
Nephrolithiasis, the patient should be provided with medications like sodium citrate and
potassium citrate so that they could overcome their health complications. However, in such
condition, surgery or shock wave lithotripsy should be included for effective care and
intervention as depending upon the size of the stone, the interventions are determined (Bath
et al., 2018). Further, for any non- glomerular disease condition, due to which the patient

2CASE STUDY ANALYSIS
suffered from critical health condition, the biopsy of the organ should be conducted so that
presence of any irregularity could be observed and effective step could be taken for its
treatment (Pochineni, Randhawa & Puttarajappa, 2018).
Application of health promotional activities
The health promotional program that would be implemented in this disease condition
for the patient suffering from hematuria would be improving his water intake and
determining lifestyle changes (Hasan, Patel & Siegert, 2019). The patient would be asked to
consume more water so that his glomerular and kidney functions could be regulated and his
Nephrolithiasis related conditions could be relieved. Further, the patient would be asked to
perform physical activity so that he could gain control over his bodily system and develop
abilities for the improvement of his hematuria condition (Filion et al., 2017).
Evaluation of current treatment
As the patient is suffering from hematuria, and has a history of ulcerative colitis,
evaluation of his health condition should be conducted depending upon his pain level, his
severity of blood loss in hematuria and his health improvement after the consumption of
medications (Bath et al., 2018). The patient would be screened quarterly for his health
improvement and hi urine sample would be the primary source using which his health
improvement would be analyzed (Bolenz et al., 2018). Hence, this is the way the health
improvement of the patient condition would be analyzed and evaluated.

3CASE STUDY ANALYSIS
References
Bath, N. M., Williams, D. H., Sollinger, H. W., & Redfield III, R. R. (2018). Commentary:
Loin Pain Hematuria Syndrome. Journal of rare diseases research & treatment, 3(4),
1.
Bolenz, C., Schröppel, B., Eisenhardt, A., Schmitz-Dräger, B. J., & Grimm, M. O. (2018).
The investigation of hematuria. Deutsches Ärzteblatt International, 115(48), 801.
Chaudhary, K., Panda, A., & Devasia, A. (2018). Spontaneous irreducible urethral prolapse
in a post-menopausal woman: a rare differential diagnosis of an intralabial
mass. International urogynecology journal, 29(7), 1067-1068.
Filion, C. M., Rodrigues, L., Johannes, C., & Masic, A. (2017). The in vitro and in vivo anti-
cancer potential of Mycobacterium cell wall fraction (MCWF) against canine
transitional cell carcinoma of the urinary bladder. Acta veterinaria, 67(4), 477-494.
Hasan, O., Patel, A. A., & Siegert, J. J. (2019). A New Differential Diagnosis: Synthetic
Cannabinoid-Associated Gross Hematuria. Case reports in medicine, 2019.
Pochineni, V., Randhawa, P., & Puttarajappa, C. (2018). Fever and Gross Hematuria in
Kidney Transplant Recipient. American Journal of Kidney Diseases, 72(4), A15-A18.